Cyclin D2 is a critical mediator of exercise-induced cardiac hypertrophy

Abstract

A number of signaling pathways underlying pathological cardiac hypertrophy have been identified. However, few studies have probed the functional significance of these signaling pathways in the context of exercise or physiological pathways. Exercise studies were performed on females from six different genetic mouse models that have been shown to exhibit alterations in pathological cardiac adaptation and hypertrophy. These include mice expressing constitutively active glycogen synthase kinase-3β (GSK-3βS9A), an inhibitor of CaMK II (AC3-I), both GSK-3βS9A and AC3-I (GSK-3βS9A/AC3-I), constitutively active Akt (myrAkt), mice deficient in MAPK/ERK kinase kinase-1 (MEKK1), and mice deficient in cyclin D2 (cyclin D2). Voluntary wheel running performance was similar to NTG littermates for five of the mouse lines. Exercise induced significant cardiac growth in all mouse models except the cyclin D2 mice. Cardiac function was not impacted in the cyclin D2 mice and studies using a phospho-antibody array identified six proteins with increased phosphorylation (greater than 150%) and nine proteins with decreased phosphorylation (greater than 33% decrease) in the hearts of exercised cyclin D2 mice compared to exercised NTG littermate controls. Our results demonstrate that unlike the other hypertrophic signaling molecules tested here, cyclin D2 is an important regulator of both pathologic and physiological hypertrophy. Impact statement This research is relevant as the hypertrophic signaling pathways tested here have only been characterized for their role in pathological hypertrophy, and not in the context of exercise or physiological hypertrophy. By using the same transgenic mouse lines utilized in previous studies, our findings provide a novel and important understanding for the role of these signaling pathways in physiological hypertrophy. We found that alterations in the signaling pathways tested here had no impact on exercise performance. Exercise induced cardiac growth in all of the transgenic mice except for the mice deficient in cyclin D2. In the cyclin D2 null mice, cardiac function was not impacted even though the hypertrophic response was blunted and a number of signaling pathways are differentially regulated by exercise. These data provide the field with an understanding that cyclin D2 is a key mediator of physiological hypertrophy.

Aerobic Exercise Ameliorates Myocardial Fibrosis via Affecting Vitamin D Receptor and Transforming Growth Factor-β1 Signaling in Vitamin D-Deficient Mice

“…The increase in heart weight was mainly related to an increase in myocardial CSA. An increasing number of studies have shown that exercise can induce physiological hypertrophy of the heart [ 79 , 80 , 81 ]. Physiologically, hypertrophic hearts maintain or increase systolic function without cell death, while pathologically hypertrophic hearts are often accompanied by cardiomyocyte death, myocardial fibrosis, and systolic dysfunction, which will further progress to heart failure [ 82 ].…”

The Neural Progenitor Cell‐Associated Transcription Factor FoxG1 Regulates Cardiac Epicardial Cell Proliferation

“…We used this early timepoint to investigate epicardial gene expression associated with cardiac remodeling. Voluntary wheel running has been shown to induce physiological cardiac hypertrophy, as measured by heart weight to body weight and cardiomyocyte cross-sectional area [35][36][37]. The DAVID analysis identified genes with significant changes in expression and grouped them into three major GO domains: biological process, cellular process, and molecular function.…”

“…Soluble angiogenin binds endothelial cell surface receptors, is endocytosed, and then is trafficked to the nucleus where it participates in ribosomal RNA transcription to promote endothelial cell proliferation [42][43][44]. Nuclear translocation of angiogenin was shown to be required for VEGFstimulated angiogenesis [36,45].…”

Animal exercise studies in cardiovascular research: Current knowledge and optimal design—A position paper of the Committee on Cardiac Rehabilitation, Chinese Medical Doctors’ Association

“…Although it is not practical to measure exercise capacity in voluntary wheel-running rodents, growing evidence has shown that voluntary wheel running can significantly increase VO 2max in these rodents, although to a much less extent than treadmill running. 81 Unlike the intensity-dependent effects of treadmill running on physiological cardiac hypertrophy, voluntary wheel running for 3−4 weeks in mice 83 , 85 , 86 and 6−8 weeks in rats 87 , 88 , 89 , 90 can induce physiological cardiac hypertrophy. Voluntary wheel running-induced physiological cardiac hypertrophy shows different transcriptomic and metabolomic profiles compared to pathological hypertrophy.…”